Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025

Executive Summary

• Delivra Health Brands Inc. reported FY 2025 net revenue of $13.37 M, an 8% increase year‑over‑year, driven by strong e‑commerce and retail growth for Dream Water® and LivRelief™ brands.
• Gross profit rose to $6.78 M (51% margin), but Adjusted EBITDA fell to $0.64 M from $0.87 M due to higher marketing and innovation spend.
• The company posted a net loss of $1.19 M for FY 2025, offset by operational improvements and a revised route‑to‑market strategy for its licensed LivRelief™ Infused business.

Key Details

• Revenue: $13,370 k in FY 2025 vs. $12,378 k in FY 2024 (+8%).
• Gross Profit / Margin: $6,778 k (51%) vs. $6,399 k (52%) FY 2024.
• Expenses (ex‑non‑cash): $6,071 k FY 2025 vs. $5,774 k FY 2024 (+5%).
• General & Administration: $4,115 k (down $110 k).
• Sales & Marketing: $1,956 k (up $407 k) – includes two major campaigns launched Nov 2024 (“Shush Your Mind” & “Quiets Chronic Pain”).
• Adjusted EBITDA: $643 k FY 2025 vs. $871 k FY 2024 (decline due to increased marketing, innovation and sales investments).
• Net Profit/Loss: Loss of $1,190 k in FY 2025 versus profit of $876 k in FY 2024.
• Operating Cash Flow: Net cash used in operations of $(754) k (FY 2024 provided $756 k).
• Brand Performance:
• Dream Water® USA & Canada: double‑digit revenue growth in e‑commerce and retail channels.
• LivRelief™: double‑digit growth in e‑commerce; however, licensed LivRelief™ Infused business saw reduced revenues, prompting a revised route‑to‑market strategy.
• Management Outlook: CEO Gord Davey highlighted confidence in continued top‑line growth via major retail partnerships, global expansion opportunities, and new product pipeline.

Notable Quotes

“Delivra Health Brands is pleased to report double‑digit revenue growth for Dream Water® USA and Dream Water® Canada… These strong results were partially offset by a reduction in revenue in our licensed LivRelief™ Infused business, however, we are revising its route‑to‑market strategy…” – Gord Davey, President & CEO

“Looking forward, strong traction with major retail customers, opportunities for global expansion, and a pipeline of innovative new products give us confidence that we can achieve significantly improved top line and bottom‑line results for the Company in the coming year.” – Gord Davey, President & CEO